The Role of Interferon, Inflammation and Infection in Aplastic Anemia
Authors: MacNamara Katherine C. 
Published: November 2019

Bone marrow failure (BMF) syndromes are a group of acquired and inherited diseases characterized by failed production of blood and immune cells, and profound bone marrow aplasia. Acquired BMF, including severe aplastic anemia (SAA), has been linked to radiation, chemical exposure, and infection, and the precise mechanisms of disease likely differ on a case-by-case basis. Inflammation and immune-mediated destruction of the marrow is a key driver of SAA, thus disease management centers on immunosuppressive therapy (IST) and, especially in young patients, bone marrow transplantation (BMT). However, not all patients are good transplant candidates and IST responsiveness varies, therefore, more specific treatments are necessary. HSC loss is a key feature of SAA, though it has been unclear if inflammation depletes HSCs directly or does so through the microenvironment. Interferons (IFNs) are proteins produced in response to microbial infections that play key roles in limiting pathogen spread and eradicating infections. While transient inflammatory responses and IFN production are often necessary for appropriate host defense, elevated levels of IFN-gamma (IFNγ) have long been associated with BMF syndromes, and type I IFNs (alpha and beta) are well documented to cause bone marrow aplasia during viral infection 1. In models of infection and inflammation IFNs can activate HSCs to proliferate and differentiate, but can also impair proliferation, and in both cases result in restricting HSC self-renewal 2-5. The precise mechanisms whereby IFNs mediate SAA and whether IFNs act directly on HSCs have remained elusive. In a mouse model of SAA driven by T cell-derived IFNγ we found that IFNγ-dependent HSC loss was associated with reduced marrow stromal cells, but a marked preservation of bone marrow-resident macrophages (MΦs) 6. Our data were consistent with findings from SAA patient marrow that also demonstrates MΦ persistence, despite significant reductions in nearly all other stromal and hematopoietic cell types 7. Moreover, we found that IFNγ was necessary for the maintained pool of MΦs. Depleting MΦs using Clodronate-loaded liposomes, or abrogating IFNγ signaling specifically in MΦs was shown to rescue HSCs and reduce SAA-associated mortality. Targeting MΦs during SAA improved thrombocytopenia, increased BM megakaryocytes, preserved platelet-primed HSCs, and increased the platelet-repopulating capacity of transplanted HSCs 6. During SAA IFNγ and MΦs were required for elevated levels of particular chemokines in the bone marrow, including CCL3, CCL4, and CCL5, which were further identified as downstream targets for mitigating SAA pathogenesis. The identification of MΦ function as a key determinant of IFNγ-dependent HSC loss in SAA furthers our understanding of disease pathogenesis and illustrates an important role for the microenvironment in SAA. These studies may reveal potential therapeutic strategies to complement current treatments for SAA that avoid generalized immunosuppression and potentially improve long-term outcomes.

Smith JN, Kanwar VS, MacNamara KC. Hematopoietic Stem Cell Regulation by Type I and II Interferons in the Pathogenesis of Acquired Aplastic Anemia. Frontiers in immunology. 2016;7:330. Baldridge MT, King KY, Boles NC, Weksberg DC, Goodell MA. Quiescent haematopoietic stem cells are activated by IFN-gamma in response to chronic infection. Nature. 2010;465(7299):793-797. de Bruin AM, Demirel O, Hooibrink B, Brandts CH, Nolte MA. Interferon-gamma impairs proliferation of hematopoietic stem cells in mice. Blood. 2013;121(18):3578-3585. MacNamara KC, Jones M, Martin O, Winslow GM. Transient activation of hematopoietic stem and progenitor cells by IFNgamma during acute bacterial infection. PLoS One. 2011;6(12):e28669. Matatall KA, Jeong M, Chen S, et al. Chronic Infection Depletes Hematopoietic Stem Cells through Stress-Induced Terminal Differentiation. Cell reports. 2016;17(10):2584-2595. McCabe A, Smith JNP, Costello A, Maloney J, Katikaneni D, MacNamara KC. Hematopoietic stem cell loss and hematopoietic failure in severe aplastic anemia is driven by macrophages and aberrant podoplanin expression. Haematologica. 2018;103(9):1451-1461. Park M, Park CJ, Jang S, et al. Reduced expression of osteonectin and increased natural killer cells may contribute to the pathophysiology of aplastic anemia. Appl Immunohistochem Mol Morphol. 2015;23(2):139-145.

Disclosures

No relevant conflicts of interest to declare.